Materias dentro de su búsqueda.
Mostrando 1,221 - 1,240 Resultados de 16,624 Para Buscar '"hepatitis B"', tiempo de consulta: 0.30s Limitar resultados
  1. 1221
    “…BACKGROUND: We evaluated the diagnostic accuracy of aspartate aminotransferase (AST)-to-platelet ratio index (APRI), fibrosis-4 index (FIB-4), AST/alanine aminotransferase (ALT) ratio (AAR), and age-platelet index (API) for significant fibrosis (Metavir F2–4) in low-replicative (HBV DNA <20,000 IU/mL) chronic hepatitis B virus (HBV) patients. METHODS: The sensitivity, specificity, and area under the receiver-operating characteristic curve (AUROC) of HBeAg-negative, low-replicative (n = 213) and high-replicative (HBV DNA ≥20,000 IU/mL, n = 153) patients was assessed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B
  2. 1222
    por Huy Do, Son
    Publicado 2015
    “…Vietnam has been a highly endemic country of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections with high hepatitis B surface antigen (HBsAg) rate (8.8-19.0%) and high anti-HCV rate (1.0-3.3%) among general population. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epidemiology of Hepatitis B and C Virus Infections and Liver Cancer in Vietnam
  3. 1223
    por Macedo, Guilherme
    Publicado 2015
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Inactive Carriers of Hepatitis B Virus: A Never Ending Story
  4. 1224
    “…INTRODUCTION: The natural history of patients with inactive hepatitis B virus (HBV) is still unclear, persisting doubts about the optimal management of these patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis B Virus Inactive Carriers: Which Follow-up Strategy?
  5. 1225
    “…BACKGROUND: Indigenous populations globally are disproportionately affected by chronic hepatitis B virus (HBV) infection however contemporary sero-prevalence data are often absent. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population
  6. 1226
    “…AIM: The aim of this study was to explain the perception of patients with chronic hepatitis B regarding problems in the Iranian society. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A qualitative study on individual experiences of chronic hepatitis B patients
  7. 1227
    “…BACKGROUND: The reduction of the incidence of hepatitis B virus (HBV) infection in Cuba can be attributed to the effectiveness of the national immunization program. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Current Condition of Chronic Hepatitis B Virus Infection in Cuban Adults
  8. 1228
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    WHO guidelines on testing for hepatitis B and C – meeting targets for testing
  9. 1229
    “…OBJECTIVES: To compare rates of all-cause, liver-related, and AIDS-related mortality among individuals who are HIV-monoinfected with those coinfected with HIV and hepatitis B (HBV) and/or hepatitis C (HCV) viruses. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis B, hepatitis C, and mortality among HIV-positive individuals
  10. 1230
    “…Hepatitis B virus (HBV) is a major etiologic agent of acute and chronic hepatitis, and end-stage liver disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis B Virus and DNA Damage Response: Interactions and Consequences for the Infection
  11. 1231
    “…Chronic hepatitis B viral infection (HBV) afflicts around 250 million individuals globally and few options for treatment exist. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A multi-scale spatial model of hepatitis-B viral dynamics
  12. 1232
    “…Sodium taurocholate cotransporting polypeptide (NTCP) was identified as an entry receptor for hepatitis B virus (HBV) infection. The substitution of serine at position 267 of NTCP with phenylalanine (S267F) is an Asian-specific variation that hampers HBV entry in vitro. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effect of S267F variant of NTCP on the patients with chronic hepatitis B
  13. 1233
    “…BACKGROUND: The risk of Hepatitis B virus (HBV) reactivation in patients with different hematological malignancy except lymphoma were rarely known before. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
  14. 1234
    “…BACKGROUND: Infections caused by Hepatitis B are one of the world health’s most serious problems. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis B virus Genotypes in West Azarbayjan Province, Northwest Iran
  15. 1235
    “…BACKGROUND: Adherence to medication is an important aspect of preventing drug resistance and treatment failure in patients receiving nucleos(t)ide analogues for chronic hepatitis B. AIMS: To assess adherence to nucleoside/nucleotide analogues in chronic hepatitis B treatment and to determine factors associated with non-adherence. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Adherence to Nucleoside/Nucleotide Analogue Treatment in Patients with Chronic Hepatitis B
  16. 1236
    “…Background: Globally, of the 248 million people chronically infected with the hepatitis B virus (HBV), 74 million reside in China. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B
  17. 1237
    “…BACKGROUND: Hepatitis B virus (HBV) exerts an intense impact on host lipid metabolism. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B
  18. 1238
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A research agenda for curing chronic hepatitis B virus infection
  19. 1239
    “…Chronic hepatitis B infection is also an important public health problem in Ghana. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis B At-Birth Dose Vaccine: An Urgent Call for Implementation in Ghana
  20. 1240
    por Friedman, Avner, Siewe, Nourridine
    Publicado 2018
    “…Hepatitis B virus (HBV) infection is a liver disorder that can result in cirrhosis, liver failure and hepatocellular carcinoma. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Chronic hepatitis B virus and liver fibrosis: A mathematical model
Herramientas de búsqueda: RSS